Continuous Effect Of Rehabilitation Training On Pulmonary Arterial Hypertension Patients

Recruiting now · Not applicable

Conditions studied: Pulmonary Hypertension

In brief

This multicenter, open label, double-arm study aims at investigating the the continuous effect of long-Term rehabilitation training on clinical improvement(ITTCI) and cardiopulmonary function in pulmonary arterial hypertension patients

Key facts

Study ID

NCT07149935

Run by

RenJi Hospital

People needed

104

Starts

2024-09-01

Expected to finish

2026-12-01

Last updated by the study team

2025-09-02

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who suffered from pre-capillary PAH (mPAP ≥ 20 mmHg, PVR > 2 Woods unit, PAWP ≤ 15 mmHg) confirmed by right heart catheterisation.
• Patients who are in the status of WHO-FC I-III.
• Patients between 18 and 75 years old
• Female subjects are not pregnant.
• Patients are treated with PAH-targeted drugs and are in a stable state and there is no progress of disease).
• Patients have not received exercise rehabilitation training within six months.

You may not qualify if…

• Patients with the following diseases or symptoms:
• Pulmonary vascular occlusive disease
• Respiratory diseases
• Ischaemic heart disease, complex congenital heart disease (e.g., tetralogy of Fallot, etc.), cardiomyopathy, valvular disease
• Active liver disease
• Severe kidney disease
• Motor disorders (e.g. lower limb fracture, ataxia, etc.)
• Malignant tumour diseases
• Physical disability
• Hb ≤ 80g / L
• Systolic blood pressure ≤85mmHg
• History of syncope within 3 months
• History of supraventricular or ventricular arrhythmia at rest within 3 months.

Where it is running

• Renji Hospital — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.